ArticleCancer gene therapy2023

LAMC2 promotes EGFR cell membrane localization and acts as a novel biomarker for tyrosine kinase inhibitors (TKIs) sensitivity in lung cancer.

Dongdong Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.